What this means
Researchers plan to gather shared data to find people at risk of frailty. The study has not reported results, so it does not yet show whether any approach works.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 50 and over
- Where
- 1 site
The science
- Registered title
- Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention
- Trial ID
- NCT06073106 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Stroke, Traumatic Brain Injury, Knee Osteoarthritis, Breast Cancer
- Sponsor
- Tan Tock Seng Hospital
- Ages
- 50 Years to no maximum
- Dates
- First posted Oct 10, 2023 · updated Oct 2, 2026
Registry summary
The aging population and its accompanying burden from non-communicable chronic diseases predicts an increasing impact imposed by frailty on healthcare systems. This is due to a lack of normative data for older adults and reliable risk stratification methods to develop effective approaches to the prevention of frailty.
In this study, the investigators plan to form a common dataset for phenotype identification, risk stratification of frailty and its targeted treatment plans in the at-risk and mildly frail population.
Sites (1)
- Tan Tock Seng Hospital, Singapore, Singapore, Singapore